ALPINE IMMUNE SCIENCES, INC. Debt Securities, Available-for-sale
ALPINE IMMUNE SCIENCES, INC. had Debt Securities, Available-for-sale of $356.27 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2024-05-09
- 2024-03-31: Debt Securities, Available-for-sale $356.27M.
- 2023-12-31: Debt Securities, Available-for-sale $364.58M.
- 2023-09-30: Debt Securities, Available-for-sale $224.64M.
- 2023-06-30: Debt Securities, Available-for-sale $236.64M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-03-31 | $356.27M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $364.58M 10-Q · filed 2024-05-09 |
| 2023-09-30 | $224.64M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $236.64M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $245.37M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $270.75M 10-K · filed 2024-03-20 |
| 2022-09-30 | $272.17M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $196.85M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $216.88M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $197.54M 10-K · filed 2023-03-23 |
| 2021-09-30 | $217.71M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $97.69M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $113.63M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $128.59M 10-K · filed 2022-03-17 |
| 2020-06-30 | $29.05M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $29.02M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $36.89M 10-K · filed 2021-03-18 |
| 2019-09-30 | $45.71M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $51.92M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $62.06M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $51.69M 10-K · filed 2020-03-30 |
| 2018-09-30 | $59.37M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $69.53M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $78.92M 10-K · filed 2019-03-18 |